This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Hallucinogens: Difference between revisions
Jump to navigation
Jump to search
>Atrpntime m Added link to Aminita Muscaria to Muscimol in the list of hallucinogens, |
>Blackhole m Reverted edits by Kai (talk) to last revision by David Hedlund |
||
| (18 intermediate revisions by 9 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''Hallucinogens''' are a class of [[psychoactive substances]] that produce powerful alterations in perception, mood, and various cognitive processes.<ref>Nichols, D. E. | '''Hallucinogens''' are a class of [[psychoactive substances]] that produce powerful alterations in perception, mood, and various cognitive processes.<ref>{{cite journal | vauthors=((Nichols, D. E.)) | journal=Pharmacology & Therapeutics | title=Hallucinogens | volume=101 | issue=2 | pages=131–181 | date= February 2004 | url=https://linkinghub.elsevier.com/retrieve/pii/S0163725803001657 | issn=01637258 | doi=10.1016/j.pharmthera.2003.11.002}}</ref> Hallucinogens represent one of the three major classes of psychoactive substances: the other two are [[stimulants]] ("uppers") and [[depressants]] ("downers"). | ||
Some claim hallucinogens can be fundamentally distinguished from stimulants and depressants. Rather than merely amplifying or dulling existing states of consciousness, they are said to produce qualitatively unique states, in which the environment and self are perceived in a new fashion. | |||
A notable aspect of hallucinogens — particularly psychedelics — is that they are often reported to be able to facilitate introspective or therapeutic processes. Hallucinogenic experiences are often compared to non-ordinary forms of consciousness such as [[lucid dreaming]], trance [[meditation]], [[hallucinations]], [[dreams]], and states of [[psychosis]]. | |||
Hallucinogens can be classified into three categories: | Hallucinogens can be classified into three categories: | ||
| Line 11: | Line 13: | ||
*'''[[deliriants]]''' (e.g. [[DPH]], [[scopolamine]], [[datura]], etc) | *'''[[deliriants]]''' (e.g. [[DPH]], [[scopolamine]], [[datura]], etc) | ||
Each category is associated with a unique mechanism of action, subjective effects, therapeutic potential, and | Each category is associated with a unique mechanism of action, subjective effects, therapeutic properties, abuse potential, and toxicity risks. | ||
Despite their | Hallucinogens that have a history of [[transpersonal|spiritual or shamanic experiences]] are known as [[entheogen]]s. | ||
Despite what their names suggest, most hallucinogens induce pseudo-hallucinations rather than 'true' hallucinations (i.e. which cannot be distinguished from normal reality). Pseudohallucinations, on the other hand, are recognized as such by the user.<ref>{{cite journal|last1=Telles-Correia|first1=Diogo|last2=Moreira|first2=Ana Lúcia|last3=Gonçalves|first3=João S.|title=Hallucinations and related concepts—their conceptual background|journal=Frontiers in Psychology|volume=6|pages=991|year=2015|issn=1664-1078|doi=10.3389/fpsyg.2015.00991|pmid=26283978|pmc=4515540|oclc=701805890}}</ref> These are common with psychedelics and dissociatives, while 'true' hallucinations are usually induced by deliriants. | |||
It is highly advised to use [[harm reduction practices]] if using these substances. | |||
==List of hallucinogens== | ==List of hallucinogens== | ||
| Line 58: | Line 64: | ||
*[[4-AcO-DET]] (''Ethacetin'') | *[[4-AcO-DET]] (''Ethacetin'') | ||
*[[4-AcO-DMT]] (''Psilacetin'') | *[[4-AcO-DMT]] (''Psilacetin'') | ||
*[[4-AcO-DPT]] | *[[4-AcO-DPT]] (''Pracetin'') | ||
*[[4-AcO-DiPT]] (''Ipracetin'') | *[[4-AcO-DiPT]] (''Ipracetin'') | ||
*[[4-AcO-EPT]] | *[[4-AcO-EPT]] (''Epracetin'') | ||
*[[4-AcO-MET]] (''Metacetin'', ''Azomet'') | *[[4-AcO-MET]] (''Metacetin'', ''Azomet'') | ||
*[[4-AcO-MPT]] | *[[4-AcO-MPT]] (''Mepracetin'') | ||
*[[4-AcO-MiPT]] (''Mipracetin'') | *[[4-AcO-MiPT]] (''Mipracetin'') | ||
*[[4-HO-DET]] (''Ethocin'') | *[[4-HO-DET]] (''Ethocin'') | ||
*[[4-HO-DMT]] (''Psilocin'') | *[[4-HO-DMT]] (''Psilocin'') | ||
*[[4-HO-DPT]] | *[[4-HO-DPT]] (''Procin'') | ||
*[[4-HO-DiPT]] (''Iprocin'') | *[[4-HO-DiPT]] (''Iprocin'') | ||
*[[4-HO-EPT]] | *[[4-HO-EPT]] (''Eprocin'') | ||
*[[4-HO-MET]] (''Metocin'') | *[[4-HO-MET]] (''Metocin'') | ||
*[[4-HO-MPT]] | *[[4-HO-MPT]] (''Meprocin'') | ||
*[[4-HO-MiPT]] (''Miprocin'') | *[[4-HO-MiPT]] (''Miprocin'') | ||
*[[4-PO-DMT]] (''Psilocybin'') | *[[4-PO-DMT]] (''Psilocybin'') | ||
*[[5-HO-DMT]] (''Bufotenin'') | *[[5-HO-DMT]] (''Bufotenin'') | ||
*[[5-MeO-DALT]] | *[[5-MeO-DALT]] (''Foxtrot'') | ||
*[[5-MeO-DMT]] | *[[5-MeO-DMT]] | ||
*[[5-MeO-DiPT]] (''Foxy'') | *[[5-MeO-DiPT]] (''Foxy'') | ||
| Line 92: | Line 98: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[2C-x]]</h4> | <h4 class="media-heading">[[2C-x]] series</h4> | ||
*[[2C-B]] | *[[2C-B]] | ||
*[[2C-C]] | *[[2C-C]] | ||
*[[2C-D]] | *[[2C-D]] | ||
| Line 102: | Line 107: | ||
*[[2C-I]] | *[[2C-I]] | ||
*[[2C-P]] | *[[2C-P]] | ||
*[[ßk-2C-B]] | |||
</li> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[2C-T-x]] series</h4> | |||
*[[2C-T]] | |||
*[[2C-T-2]] | *[[2C-T-2]] | ||
*[[2C-T-21]] | *[[2C-T-21]] | ||
*[[2C-T-7]] | *[[2C-T-7]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[DOx]]</h4> | <h4 class="media-heading">[[DOx]] series</h4> | ||
*[[DOB]] | *[[DOB]] | ||
*[[DOC]] | *[[DOC]] | ||
| Line 117: | Line 127: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[25x-NBOMe]]</h4> | <h4 class="media-heading">[[25x-NBOMe]] series</h4> | ||
*[[25B-NBOMe]] | *[[25B-NBOMe]] | ||
*[[25C-NBOMe]] | *[[25C-NBOMe]] | ||
| Line 126: | Line 136: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[25x-NBOH]]</h4> | <h4 class="media-heading">[[25x-NBOH]] series</h4> | ||
*[[25B-NBOH]] | *[[25B-NBOH]] | ||
*[[25C-NBOH]] | *[[25C-NBOH]] | ||
*[[25I-NBOH]] | *[[25I-NBOH]] | ||
</li> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[Benzofurans]]</h4> | |||
*[[2C-B-FLY]] | |||
*[[5-MeO-DiBF]] | |||
*[[Bromo-DragonFLY]] | |||
</li> | </li> | ||
| Line 135: | Line 152: | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
*[[3C-E]] | *[[3C-E]] | ||
*[[Efavirenz]] | *[[Efavirenz]] | ||
*[[TMA-2]] | *[[TMA-2]] | ||
| Line 150: | Line 165: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
*[[Acacia confusa]] | *[[Acacia confusa]] | ||
*[[ | *[[Amanita muscaria]] | ||
*[[Ayahuasca]] | *[[Ayahuasca]] | ||
*[[Banisteriopsis caapi]] | *[[Banisteriopsis caapi]] | ||
*[[Brugmansia]] | |||
*[[Cannabis]] | *[[Cannabis]] | ||
*[[Chacruna]] | *[[Chacruna]] | ||
| Line 277: | Line 293: | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[GABA|GABA-A receptor agonists]]</h4> | <h4 class="media-heading">[[GABA|GABA-A receptor agonists]]</h4> | ||
*[[ | *[[Muscimol]] | ||
*[[Z-drug|Z-drugs]] | *[[Z-drug|Z-drugs]] | ||
**[[Zaleplon]] | **[[Zaleplon]] | ||
| Line 330: | Line 346: | ||
[[Category:Psychoactive class]] | [[Category:Psychoactive class]] | ||
[[Category:Hallucinogen|*]] | [[Category:Hallucinogen|*]] | ||
{{#set:Featured=true}} | |||
Latest revision as of 17:20, 2 June 2024
Hallucinogens are a class of psychoactive substances that produce powerful alterations in perception, mood, and various cognitive processes.[1] Hallucinogens represent one of the three major classes of psychoactive substances: the other two are stimulants ("uppers") and depressants ("downers").
Some claim hallucinogens can be fundamentally distinguished from stimulants and depressants. Rather than merely amplifying or dulling existing states of consciousness, they are said to produce qualitatively unique states, in which the environment and self are perceived in a new fashion.
A notable aspect of hallucinogens — particularly psychedelics — is that they are often reported to be able to facilitate introspective or therapeutic processes. Hallucinogenic experiences are often compared to non-ordinary forms of consciousness such as lucid dreaming, trance meditation, hallucinations, dreams, and states of psychosis.
Hallucinogens can be classified into three categories:
- psychedelics (e.g. LSD, psilocybin mushrooms, DMT, etc.)
- dissociatives (e.g. ketamine, PCP, DXM, etc.)
- deliriants (e.g. DPH, scopolamine, datura, etc)
Each category is associated with a unique mechanism of action, subjective effects, therapeutic properties, abuse potential, and toxicity risks.
Hallucinogens that have a history of spiritual or shamanic experiences are known as entheogens.
Despite what their names suggest, most hallucinogens induce pseudo-hallucinations rather than 'true' hallucinations (i.e. which cannot be distinguished from normal reality). Pseudohallucinations, on the other hand, are recognized as such by the user.[2] These are common with psychedelics and dissociatives, while 'true' hallucinations are usually induced by deliriants.
It is highly advised to use harm reduction practices if using these substances.
List of hallucinogens
See also
External links
Literature
- Nichols, D. E. (2004). Hallucinogens. Pharmacology & therapeutics, 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002
References
- ↑ Nichols, D. E. (February 2004). "Hallucinogens". Pharmacology & Therapeutics. 101 (2): 131–181. doi:10.1016/j.pharmthera.2003.11.002. ISSN 0163-7258.
- ↑ Telles-Correia, Diogo; Moreira, Ana Lúcia; Gonçalves, João S. (2015). "Hallucinations and related concepts—their conceptual background". Frontiers in Psychology. 6: 991. doi:10.3389/fpsyg.2015.00991. ISSN 1664-1078. OCLC 701805890. PMC 4515540
. PMID 26283978.